A Holistic Unani Therapeutic Approach to Facial Palsy (Laqwa) in a Paediatric Patient: A Case Report

Abstract

Laqwa (facial palsy) is the most common motor neuropathy of the seventh cranial nerve, presenting with sudden-onset unilateral facial weakness and asymmetry. The condition occurs across all age groups, with paediatric cases often causing significant functional and psychological distress. The majority of cases are idiopathic, corresponding to Bell’s palsy, which accounts for nearly 60–75% of all unilateral facial paralysis cases. The global annual incidence is estimated at 15–30 per 100,000 population, with noted cases in children as well. This case report aims to evaluate the clinical response of Unani management in an 11-year-old child with Bell’s palsy.

Classical Unani physicians, including Rabban Tabri, Ibn Sina, and Zakariya Razi, described Laqwa in detail in terms of etiology, pathogenesis, and therapeutic approaches. Their treatment principles aim at restoring equilibrium of Akhlat (humors), relieving nerve inflammation, improving muscular tone, and enhancing neural function. Evidence-based Unani therapies such as Ilaj-bil-Dawa (pharmacotherapy) and Ilaj-bit-Tadbeer (regimenal therapy) have been traditionally used for successful management of Laqwa with minimal adverse effects. The patient received Unani formulations including Ikseer Azaraqi, Joshanda Mundij, Ikseer Momiyai, and Habb-e-Balchad for four weeks.

No history of trauma, ear infection, stroke, tumour, metabolic disorder, or other neurological disease was present. Clinical presentation and neurological examination supported the diagnosis of idiopathic lower motor neuron facial palsy (Bell’s palsy). The patient was treated with selected Unani pharmacological formulations known for musculoskeletal strengthening, anti-inflammatory effects, and nerve rejuvenation to improve facial muscle tone and circulation. Significant clinical improvement was observed within the first two weeks, with complete recovery achieved subsequently without any complications.

This case highlights the potential of Unani medicine as an effective, safe, and holistic therapeutic modality for paediatric Laqwa (facial palsy). Early Unani intervention may accelerate recovery, reduce emotional impact in children, and prevent long-term sequelae. More clinical studies are warranted to further validate the role of Unani therapeutics in facial nerve disorders. This case suggests potential benefit of Unani therapy; however, larger studies are required.